Influencers' fact-based criticism of brands is not defamation: Delhi High Court

In a significant move, the court affirmed that influencers can display brand names in their critiques without fear of trademark infringement claims.

By  Storyboard18Apr 29, 2025 9:39 AM
Influencers' fact-based criticism of brands is not defamation: Delhi High Court
Justice Bansal’s verdict emphasizes that influencers, often seen as trendsetters, also serve as vital watchdogs for consumers, ensuring accountability among brands.

The Delhi High Court has refused to grant a temporary injunction in favour of San Nutrition Private Limited in its plea against alleged defamation, disparagement and trademark infringement by four social media influencers who made videos featuring San Nutrition's 'Doctor's Choice' products.

The Delhi High Court cited that criticism of consumer brands, when backed by scientific evidence, does not amount to defamation. Justice Amit Bansal noted that San Nutrition nowhere questioned the genuineness of the findings in the laboratory reports relied by the defendants/influencers. The Court noted that San Nutrition only questioned the credibility of the laboratories, stating that they were not FSSAI registered.

The ruling came in response to an interim plea filed by San Nutrition Private Limited, which sued four influencers, Arpit Mangal, Kabir Grover, Manish Keshwani and Avijit Roy, for posting critical reviews of its whey protein products under the "Doctor’s Choice" label.

The Court said that the veracity of the results of the laboratory reports can only be tested at the stage of trial. It noted that they cannot be disregarded at an interim stage merely because they are not FSSAI recognized.

The court affirmed that influencers can display brand names in their critiques without fear of trademark infringement claims. It also said that satire, hyperbole and pointed criticism remain protected forms of free speech; and brands cannot shift blame onto outsourced manufacturers for false claims on product labels.

The court found that Arpit Mangal’s review was based on credible laboratory test results and upheld his defence of truth. Even language deemed harsh, such as Mangal’s description of the product as "ghatiya" (inferior) was protected, with the judge noting that lab reports supported his claims.

San Nutrition’s attempt to discredit the lab tests and disown responsibility for the label information was dismissed as "completely untenable", further reinforcing the need for brands to maintain transparency about their products.

First Published on Apr 29, 2025 8:40 AM

More from Storyboard18

Brand Marketing

Amul follows Mother Dairy, increases milk prices by Rs 2 per litre from May 1

Amul follows Mother Dairy, increases milk prices by Rs 2 per litre from May 1

Brand Marketing

Subscription booms, but brands must stop dodging royalties, says Tips Music MD Kumar Taurani

Subscription booms, but brands must stop dodging royalties, says Tips Music MD Kumar Taurani

Brand Marketing

Coldplay’s Ahmedabad concert brought ₹641 Crore economic impact: Report

Coldplay’s Ahmedabad concert brought ₹641 Crore economic impact: Report

Brand Marketing

IKEA reinvents India growth plan to reach tier-II cities

IKEA reinvents India growth plan to reach tier-II cities

Brand Marketing

Pepsi announces global female football ambassadors - Alexia Putellas, Caroline Graham Hansen, Farah Jefry and Lauren James

Pepsi announces global female football ambassadors - Alexia Putellas, Caroline Graham Hansen, Farah Jefry and Lauren James

How it Works

PwC unveils new brand identity in first global refresh in over a decade

PwC unveils new brand identity in first global refresh in over a decade

Brand Marketing

Amazon says it won't show tariff costs on products after White House criticism

Amazon says it won't show tariff costs on products after White House criticism

Brand Marketing

Starbucks leans on stores, customer experiences and marketing in bid to revive sales amid ongoing slump

Starbucks leans on stores, customer experiences and marketing in bid to revive sales amid ongoing slump